article
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc − cystine transporter: a new action for an old drug
Leukemia · 2001 · Vol. 15(10) · pp. 1633–1640
PW Gout✉(BC Cancer Agency)AR Buckley(University of Cincinnati Medical Center)CR Simms(BC Cancer Agency)Nicholas Bruchovsky(BC Cancer Agency)
Amino Acid Enzymes and MetabolismDrug Transport and Resistance MechanismsBiomedical Research and PathophysiologySulfasalazineCystineGrowth inhibitionLymphomaPharmacologyChemistryCancer researchBiologyMedicineBiochemistry
MeSH terms
AnimalsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsCarrier ProteinsCell DivisionDrug Evaluation, PreclinicalHumansInjections, IntraperitonealLymphomaNeoplasm TransplantationRats, Inbred StrainsSulfasalazineTumor Cells, CulturedInhibitory Concentration 50Amino Acid Transport System y+
Funding
- Ohio Cancer Research Associates
- BC Cancer Agency
Citations
629
FWCI
0.76
field-weighted impact
References
42
Percentile
72%
vs. same field & year
Citations per year
Cited by
The Metabolic Underpinnings of Ferroptosis
Cell Metabolism · 2020 · 1,298 citations
Ferroptosis in Cancer Cell Biology
Cancers · 2020 · 336 citations
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
eLife · 2014 · 2,015 citations
Targeting ferroptosis as a vulnerability in cancer
Nature reviews. Cancer · 2022 · 2,045 citations
Oxidative Stress in Cancer
Cancer Cell · 2020 · 2,420 citations
The development of the concept of ferroptosis
Free Radical Biology and Medicine · 2018 · 1,047 citations
Role of GPX4 in ferroptosis and its pharmacological implication
Free Radical Biology and Medicine · 2018 · 1,452 citations
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Cancer Letters · 2020 · 562 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.